302 related articles for article (PubMed ID: 12911332)
41. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
Cho HJ; Kim JK; Kim KD; Yoon HK; Cho MY; Park YP; Jeon JH; Lee ES; Byun SS; Lim HM; Song EY; Lim JS; Yoon DY; Lee HG; Choe YK
Cancer Lett; 2006 Jun; 237(1):56-66. PubMed ID: 16009487
[TBL] [Abstract][Full Text] [Related]
42. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells.
Song JH; Song DK; Herlyn M; Petruk KC; Hao C
Clin Cancer Res; 2003 Sep; 9(11):4255-66. PubMed ID: 14519653
[TBL] [Abstract][Full Text] [Related]
43. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
44. Regulation of caspase-6 and FLIP by the AMPK family member ARK5.
Suzuki A; Kusakai G; Kishimoto A; Shimojo Y; Miyamoto S; Ogura T; Ochiai A; Esumi H
Oncogene; 2004 Sep; 23(42):7067-75. PubMed ID: 15273717
[TBL] [Abstract][Full Text] [Related]
45. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L).
Lundqvist A; Nagata T; Kiessling R; Pisa P
Cancer Immunol Immunother; 2002 May; 51(3):139-44. PubMed ID: 11941452
[TBL] [Abstract][Full Text] [Related]
46. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells.
Glaser T; Wagenknecht B; Weller M
Oncogene; 2001 Aug; 20(35):4757-67. PubMed ID: 11521188
[TBL] [Abstract][Full Text] [Related]
47. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex.
Peter ME; Kischkel FC; Scheuerpflug CG; Medema JP; Debatin KM; Krammer PH
Eur J Immunol; 1997 May; 27(5):1207-12. PubMed ID: 9174612
[TBL] [Abstract][Full Text] [Related]
48. Frontline: Induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus.
Müller DB; Raftery MJ; Kather A; Giese T; Schönrich G
Eur J Immunol; 2004 Apr; 34(4):941-51. PubMed ID: 15048704
[TBL] [Abstract][Full Text] [Related]
49. Molluscum contagiosum virus inhibitors of apoptosis: The MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein.
Shisler JL; Moss B
Virology; 2001 Mar; 282(1):14-25. PubMed ID: 11259186
[TBL] [Abstract][Full Text] [Related]
50. Feedback regulation of mitochondria by caspase-9 in the B cell receptor-mediated apoptosis.
Eeva J; Nuutinen U; Ropponen A; Mättö M; Eray M; Pellinen R; Wahlfors J; Pelkonen J
Scand J Immunol; 2009 Dec; 70(6):574-83. PubMed ID: 19906200
[TBL] [Abstract][Full Text] [Related]
51. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
[TBL] [Abstract][Full Text] [Related]
52. Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells.
Abe H; Shibata MA; Otsuki Y
Mol Hum Reprod; 2006 Sep; 12(9):535-41. PubMed ID: 16870953
[TBL] [Abstract][Full Text] [Related]
53. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
Lane D; Cartier A; L'Espérance S; Côté M; Rancourt C; Piché A
Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850
[TBL] [Abstract][Full Text] [Related]
54. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
[TBL] [Abstract][Full Text] [Related]
55. Acquired resistance to Fas/CD95 ligation in U937 cells is associated with multiple molecular mechanisms.
Blomberg J; Ruuth K; Santos D; Lundgren E
Anticancer Res; 2008; 28(2A):593-9. PubMed ID: 18506997
[TBL] [Abstract][Full Text] [Related]
56. Down-regulation of AMP-activated protein kinase sensitizes DU145 carcinoma to Fas-induced apoptosis via c-FLIP degradation.
Jung SN; Park IJ; Kim MJ; Kang I; Choe W; Kim SS; Ha J
Exp Cell Res; 2009 Aug; 315(14):2433-41. PubMed ID: 19477172
[TBL] [Abstract][Full Text] [Related]
57. c-FLICE inhibitory protein expression inhibits T-cell activation.
Tai TS; Fang LW; Lai MZ
Cell Death Differ; 2004 Jan; 11(1):69-79. PubMed ID: 12970675
[TBL] [Abstract][Full Text] [Related]
58. Targeting the FLICE Inhibitory Protein (FLIP) in cancer therapy.
Wajant H
Mol Interv; 2003 May; 3(3):124-7. PubMed ID: 14993418
[TBL] [Abstract][Full Text] [Related]
59. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis.
Palao G; Santiago B; Galindo M; Payá M; Ramirez JC; Pablos JL
Arthritis Rheum; 2004 Sep; 50(9):2803-10. PubMed ID: 15457448
[TBL] [Abstract][Full Text] [Related]
60. Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal.
Kim KH; Seong BL
EMBO J; 2003 May; 22(9):2104-16. PubMed ID: 12727877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
